Abstract
In 10 of 15 patients with elevated sedimentation rates, suffering from non-rheumatic and rheumatic disorders, the sedimentation rate and the concn. of plasma fibrinogen decreased during salicylate therapy. It is suggested that the change in the fibrinogen may represent an effect of salicylate on the liver.